|
Managing the Shift to Electronic Submissions
Gina Ross
Director, Managing Consultant
Regulatory
Publishing Services
Beckloff Associates
a Cardinal Health Company
Recordings
US$249
|
 |
The
electronic common technical document (eCTD) presents many challenges
to a Sponsor organization, but may also yield significant benefits
through increased efficiencies and improved reviews by regulatory
agencies. Sponsor organizations that have decided to adopt the
eCTD now have the challenging task of managing and implementing
the paradigm shift from paper to electronic regulatory submissions.
The first of many challenges is to evaluate and modify existing
document preparation processes to accommodate differences between
paper and eCTD. Once these changes have been identified, the next
step is to convince upper management the changes are necessary
to move the organization forward to preparing electronic submissions.
Another challenge is working with vendors to receive electronically-compliant
documents. The eCTD will require sponsor organizations to rethink
their business and those with whom they do business.
This audio
conference will address:
Speaker
biography:
Gina A. Ross
has been involved in the pharmaceutical industry for over nine
years, and for most of that time has managed the document preparation
department for Beckloff Associates, Inc. (BAI), a pharmaceutical
research and scientific consulting firm. She was instrumental
in implementing the Common Technical Document (CTD) format in
her own organization. Beginning in August 2000, she began researching
how to implement electronic document management and electronic
submission capabilities within BAI. In 2002, she identified an
electronic document management system and actively participated
in the validation and implementation. BAI submitted its first
electronic submission in December 2004. Since that time, Gina
has overseen the submission of multiple electronic submissions,
including original submissions, amendments, annual reports, and
supplements, and the implementation and validation of eCTD software.
Recently, she has managed the submission of several original eCTDs
to the Office of Generic Drugs (OGD) and to various divisions
within FDA. She has also given numerous presentations on CTD and
eCTD implementation.
Who Should
Attend?
- Regulatory
Affairs
- Regulatory
Submissions
- Medical
and Scientific Writers
- Document
Management
- Document
Publishers
- Quality
Reviewers
- IT Personnel
This
audio conference is rated General Interest.
Purchase
Options:
|